Tech Company Financing Transactions
SmartCells Funding Round
SmartCells, based in Beverly, raised $1 million from private investors.
Transaction Overview
Company Name
Announced On
10/22/2008
Transaction Type
Venture Equity
Amount
$1,000,000
Round
Undisclosed
Investors
Proceeds Purpose
This investment will accelerate the commercial development of our SmartInsulin therapy for type 1 diabetes.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
100 Cummings Center 419E
Beverly, MA 01915
USA
Beverly, MA 01915
USA
Phone
Website
Email Address
Overview
SmartInsulin consists of a layered, biocompatible and biodegradable polymer-therapeutic that is bound to an engineered glucose-binding molecule. Insulin is released from SmartInsulin only when the therapeutic is unbound by the presence of a specific glucose concentration.
Management Team
Browse more venture capital transactions:
Prev: 10/22/2008: Envia Systems venture capital transaction
Next: 10/22/2008: Like.com venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on tech company VC transactions. VC investment data records reported here come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs